Drug Patents owned by Nextwave

1. List of Quillivant Xr drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8062667 NEXTWAVE Modified release formulations containing drug-ion exchange resin complexes
Mar, 2029

(5 years from now)

US8778390 NEXTWAVE Orally effective methylphenidate extended release powder and aqueous suspension product
Feb, 2031

(7 years from now)

US8956649 NEXTWAVE Orally effective methylphenidate extended release powder and aqueous suspension product
Feb, 2031

(7 years from now)

US8465765 NEXTWAVE Orally effective methylphenidate extended release powder and aqueous suspension product
Feb, 2031

(7 years from now)

US9040083 NEXTWAVE Orally effective methylphenidate extended release powder and aqueous suspension product
Feb, 2031

(7 years from now)

US8287903 NEXTWAVE Orally effective methylphenidate extended release powder and aqueous suspension product
Feb, 2031

(7 years from now)

US8563033 NEXTWAVE Orally effective methylphenidate extended release powder and aqueous suspension product
Feb, 2031

(7 years from now)

Do you want to check out QUILLIVANT XR patents from before 2022?

Drugs and Companies using METHYLPHENIDATE HYDROCHLORIDE ingredient

Market Authorisation Date: 27 September, 2012

Treatment: Treatment of a patient by administering the formulation recited in claim 1 or claim 23; Method of treating attention deficit hyperactivity disorder by administering the composition of claim 1; Treatin...

Dosage: FOR SUSPENSION, EXTENDED RELEASE;ORAL

How can I launch a generic of QUILLIVANT XR before it's patent expiration?
More Information on Dosage

QUILLIVANT XR family patents

35

United States

3

Spain

3

Australia

3

Denmark

3

European Union

2

China

2

Israel

2

Brazil

2

Canada

1

Korea, Republic of

1

Russia

1

Austria

1

Taiwan

1

Japan

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in